Home
About
Overview
Sharing Data
ORCID
Help
History (21)
Surveillance colonoscopy in ulcerative colitis: is the message loud and clear?
Long-term survival in phase II trials of gemcitabine plus cisplatin for advanced transitional cell cancer.
Decapitation
Moniliformis
In ovarian neoplasms, BRAF, but not KRAS, mutations are restricted to low-grade serous tumours.
See All 21 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
In ovarian neoplasms, BRAF, but not KRAS, mutations are restricted to low-grade serous tumours.
In ovarian neoplasms, BRAF, but not KRAS, mutations are restricted to low-grade serous tumours. J Pathol. 2004 Mar; 202(3):336-40.
View in:
PubMed
subject areas
Cystadenoma, Mucinous
Cystadenoma, Papillary
Cystadenoma, Serous
Female
Humans
Mutation
Ovarian Neoplasms
Proto-Oncogene Proteins
Proto-Oncogene Proteins B-raf
Proto-Oncogene Proteins c-raf
Proto-Oncogene Proteins p21(ras)
ras Proteins
authors with profiles
Thomas Krausz